0001178913-19-000172.txt : 20190129 0001178913-19-000172.hdr.sgml : 20190129 20190129144452 ACCESSION NUMBER: 0001178913-19-000172 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190129 DATE AS OF CHANGE: 20190129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Evogene Ltd. CENTRAL INDEX KEY: 0001574565 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-87734 FILM NUMBER: 19548388 BUSINESS ADDRESS: STREET 1: 13 GAD FEINSTEIN STREET STREET 2: PARK REHOVOT P.O.B 2100 CITY: REHOVOT STATE: L3 ZIP: 76121 BUSINESS PHONE: 97289311900 MAIL ADDRESS: STREET 1: 13 GAD FEINSTEIN STREET STREET 2: PARK REHOVOT P.O.B 2100 CITY: REHOVOT STATE: L3 ZIP: 76121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Harel Insurance Investments & Financial Services Ltd. CENTRAL INDEX KEY: 0001429390 IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 BUSINESS PHONE: 972-3-7547090 MAIL ADDRESS: STREET 1: HAREL HOUSE, 3 ABBA HILLEL ST. CITY: RAMAT GAN STATE: L3 ZIP: 52118 SC 13G/A 1 zk1922503.htm SC 13G/A zk1617904.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G/A
(Amendment No. 5)*
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND
(d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)

Under the Securities Exchange Act of 1934

EVOGENE LTD.
(Name of Issuer)
 
Ordinary Shares, par value NIS 0.02 per share
(Title of Class of Securities)
 
 
M4119S104
  
(CUSIP Number)
 
December 31, 2018
(Date of Event Which Requires Filing of this Statement)

Check the following box to designate the rule pursuant to which the Schedule is filed:

¨ Rule 13d-1(b)

x Rule 13d-1(c)

o Rule 13d-1(d)

*
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
CUSIP NO. M4119S104
 
1.
Name of Reporting Persons
 
Harel Insurance Investments & Financial Services Ltd.
2.
Check the Appropriate Box if a Member of a Group
(a)  ¨
(b)  ¨
3.
SEC Use only 
 
 
4.
Place of Organization
 
Israel
 
Number of Shares Beneficially Owned by Each Reporting Person With:
 5.
Sole Voting Power
 
0
6.
Shared Voting Power
 
1,165,592 Ordinary Shares*
7.
Sole Dispositive Power
 
0
8.
Shared Dispositive Power
 
1,165,592 Ordinary Shares*
9.
Aggregate Amount Beneficially Owned by Each Reporting Person
 
1,165,592 Ordinary Shares*
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares
 
☐
11.
Percent of Class Represented by Amount in Row (9)
 
4.5%**
12.
Type of Reporting Person:
 
CO
 
* See Item 4.
** Based on 25,754,297 Ordinary Shares issued and outstanding as of September 30, 2018 (as reported by the Issuer in Exhibit 99.1 to its Report on Form 6-K filed with the Securities and Exchange Commission on November 14, 2018).
 
- 2 -
Item 1.

(a)
Name of Issuer:
 
EVOGENE LTD. (hereinafter referred to as the “Issuer”).

(b)
Address of Issuer’s Principal Executive Offices:
 
13 Gad Feinstein Street, Park Rehovot, P.O.B 2100, Rehovot 7612002, Israel
 
Item 2.

(a)-(c)
Name of Person Filing, address and citizenship:

The following entity is referred to as the “Reporting Person” in this Statement:
Harel Insurance Investments & Financial Services Ltd., an Israeli public company, with a principal business address at Harel House; 3 Aba Hillel Street; Ramat Gan 52118, Israel.

See Item 4.

(d)
Title of Class of Securities:

Ordinary Shares, par value NIS 0.02 per share (the “Ordinary Shares”).

(e)
CUSIP Number:

M4119S104
 
Item 3.
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
Not Applicable.
 
Item 4.
Ownership
 
All of the 1,165,592 Ordinary Shares reported in this Statement as beneficially owned by the Reporting Person are held for members of the public through, among others, provident funds and/or mutual funds and/or pension funds and/or index-linked securities and/or insurance policies, which are managed by subsidiaries of the Reporting Person, each of which subsidiaries operates under independent management and makes independent voting and investment decisions. Consequently, this Statement shall not be construed as an admission by the Reporting Person that it is the beneficial owner of any of the Ordinary Shares covered by this Statement.
 
Except as set forth above, see items 5-11 of the cover pages hereto for beneficial ownership, percentage of class and dispositive power of the Reporting Person, which are incorporated herein.
 
Item 5.
Ownership of Five Percent or Less of a Class
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person
 
Not Applicable.
 
- 3 -
 
Item 7.
Identification and Classification of the Subsidiary, Which Acquired the Security Being Reported on by the Parent Holding Company
 
Not Applicable.
 
Item 8.
Identification and Classification of Members of the Group
 
Not Applicable.
 
Item 9.
Notice of Dissolution of Group
 
Not Applicable.
 
Item 10.
Certification
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
- 4 -
SIGNATURES
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
January 29, 2019
 
  HAREL INSURANCE INVESTMENTS AND FINANCIAL SERVICES LTD.  
     
 
By: /s/ Nataly Mishan-Zakai
  
     
 
Name: Nataly Mishan-Zakai, authorized signatory of HAREL
INSURANCE INVESTMENTS AND FINANCIAL
SERVICES LTD.
  
 
Title: Legal Counsel
  
 
 
- 5 -